SCHEMBL9011005

SCHEMBL9011005

O=C(O)CCc1ccc(N2CCN(C(=O)c3ccc4ccccc4c3)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.73
TSHR P16473 4/20 0.73
MAPT P10636 3/20 0.68
ALDH1A1 P00352 3/20 0.68
USP2 O75604 2/20 0.68
GAA P10253 2/20 0.68
HTT P42858 2/20 0.68
ALOX15 P16050 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
HSD17B10 Q99714 1/20 0.68
NPC1 O15118 1/20 0.58
ITGB3 P05106 1/20 0.56
ITGA2B P08514 1/20 0.56
HPGD P15428 1/20 0.54
DRD4 P21917 3/20 0.54
MAPK1 P28482 1/20 0.53
AKR1C1 Q04828 1/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9011170 0.93 LMNA (0.70) LMNATSHRMAPTALDH1A1USP2
SCHEMBL9011100 0.89 LMNA (0.70) LMNATSHRMAPTALDH1A1USP2
SCHEMBL9011009 0.88 LMNA (0.76) LMNATSHRMAPTALDH1A1USP2
SCHEMBL27298395 0.85 TSHR (1.00) LMNATSHRMAPTALDH1A1USP2
SCHEMBL7813535 0.84 LMNA (0.70) LMNATSHRMAPTALDH1A1USP2
SCHEMBL7804503 0.83 LMNA (0.68) LMNATSHRMAPTALDH1A1USP2
SCHEMBL9011328 0.82 TSHR (0.67) LMNATSHRMAPTALDH1A1USP2
SCHEMBL9010961 0.82 DRD4 (0.60) LMNATSHRNPC1HPGDDRD4
SCHEMBL7804402 0.81 LMNA (0.73) LMNATSHRMAPTALDH1A1USP2
SCHEMBL9011148 0.81 LMNA (0.62) LMNATSHRMAPTALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed